We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

65 hedge funds and large institutions have $183M invested in ChemoCentryx, Inc. in 2014 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,021% more call options, than puts

Call options by funds: $2.89M | Put options by funds: $258K

49% more capital invested

Capital invested by funds: $123M → $183M (+$60M)

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

2% more funds holding

Funds holding: 6465 (+1)

5% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 19

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
65
Holders Change
+1
Holders Change %
+1.56%
% of All Funds
1.73%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
11
Increased
20
Reduced
19
Closed
8
Calls
$2.89M
Puts
$258K
Net Calls
+$2.63M
Net Calls Change
+$2.25M
Name Holding Trade Value Shares
Change
Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$691K +$393K +74,359 +277%
BIM
27
BlackRock Investment Management
Delaware
$625K +$2.69K +509 +0.6%
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$555K
Ohio Public Employees Retirement System (OPERS)
29
Ohio Public Employees Retirement System (OPERS)
Ohio
$511K
BPC
30
Banque Pictet & Cie
Switzerland
$491K
RA
31
Royce & Associates
New York
$478K
Renaissance Technologies
32
Renaissance Technologies
New York
$437K -$23.1K -4,377 -6%
Deutsche Bank
33
Deutsche Bank
Germany
$362K +$175K +33,160 +166%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$345K +$1.14K +216 +0.4%
BBA
35
Baker Bros. Advisors
New York
$342K
CS
36
Credit Suisse
Switzerland
$328K +$142K +26,816 +126%
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
$291K -$11.9K -2,260 -5%
KeyBank National Association
38
KeyBank National Association
Ohio
$262K
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$245K +$17.2K +3,250 +10%
Charles Schwab
40
Charles Schwab
California
$240K
ProShare Advisors
41
ProShare Advisors
Maryland
$235K +$7.38K +1,395 +4%
TA
42
Teachers Advisors
New York
$232K
Two Sigma Investments
43
Two Sigma Investments
New York
$220K +$170K +32,220 New
VKH
44
Virtu KCG Holdings
New York
$187K +$145K +27,387 New
RFC
45
Russell Frank Company
Washington
$166K +$129K +24,405 New
DekaBank Deutsche Girozentrale
46
DekaBank Deutsche Girozentrale
Germany
$152K -$13.2K -2,500 -10%
NFA
47
Nationwide Fund Advisors
Ohio
$143K
Jacobs Levy Equity Management
48
Jacobs Levy Equity Management
New Jersey
$135K +$104K +19,732 New
AIG
49
American International Group
New York
$117K -$3.61K -682 -4%
SG Americas Securities
50
SG Americas Securities
New York
$100K -$28.9K -5,458 -27%

CCXI Hedge Fund Activity: Q4 2014 in Review

65 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2014, worth a combined $183M — up 49% from $123M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new CCXI positions and 8 closed out — a net gain of 3 holders — while 20 added to existing stakes and 19 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $2.11M. The largest seller was Balyasny Asset Management, cutting an estimated $5.04M.

  • 65 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q4 2014, up from 64 in Q3 2014.
  • Funds reported $183M of ChemoCentryx, Inc. stock for Q4 2014, up 49% quarter-over-quarter.
  • 11 funds opened new ChemoCentryx, Inc. positions in Q4 2014 and 8 closed out, a net change of +3 holders.
  • The largest ChemoCentryx, Inc. buyer in Q4 2014 was Fidelity Investments, an estimated $2.11M added.
  • The largest ChemoCentryx, Inc. seller in Q4 2014 was Balyasny Asset Management, an estimated $5.04M sold.

Based on aggregated 13F filings for Q4 2014.